Biopolis opens (2003)
Singapore unveiled Biopolis, a biomedical research campus built with heavy public funding to attract world-class scientists and pharma R&D. Since 2010, the government has committed more than $45 billion through its Research, Innovation, and Enterprise programmes, roughly half for biomedical and health sciences.
Pulled in research institutes, global labs, and a growing pool of biotech talent.
Grew into a hub hosting eight of the world's ten largest drugmakers and 60-plus biopharma plants.
The Singapore biotech firms now targeting Boston grew out of this campus ecosystem.
